What are BTK Degraders? with Joanna Rhodes, MD

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Dr. Joanna M. Rhodes is the Director of the Lymphoma Program at Rutgers Cancer Institute, Systems Lead for Lymphoma for RWJ Barnabas, and an Assistant Professor at the Rutgers New Jersey Medical School. She completed her medical degree at Stony Brook University School of Medicine and went on to complete her residency in Internal Medicine at New York Presbyterian- Weill Cornell. She did her fellowship at the University of Pennsylvania and also received a Master of Science in Clinical Epidemiology. She is board certified in Internal Medicine, hematology and medical oncology. Her clinical interests are in chronic lymphocytic leukemia and other lymphomas. Her research interests include the development of novel therapies for CLL and lymphomas as well as the pharmacoepidemiology of targeted agents in lymphoma and toxicity management strategies.